116
Views
13
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Clinicopathological Characteristics of Breast Cancers with Axillary Skip Metastases

, , , , , & show all
Pages 33-36 | Received 27 Apr 2011, Accepted 16 Jun 2011, Published online: 24 Jan 2012

REFERENCES

  • Chevinsky AH, Ferrara J, James AG, Prospective evaluation of clinical and pathologic detection of axillary metastases in patients with carcinoma of the breast. Surgery 1990;108:612–617; discussion 617–618.
  • Van Lancker M, Goor C, Sacre R, Patterns of axillary lymph node metastasis in breast cancer. Am J Clin Oncol. 1995;18:267–272.
  • Beriwal S, Soran A, Kocer B, Factors that predict the burden of axillary disease in breast cancer patients with a positive sentinel node. Am J Clin Oncol. 2008;31:34–38.
  • Sato K. Current technical overviews of sentinel lymph node biopsy for breast cancer. Breast Cancer 2007;14:354–361.
  • Rosen PP, Lesser ML, Kinne DW, Beattie EJ. Discontinuous or “skip” metastases in breast carcinoma. Analysis of 1228 axillary dissections. Ann Surg. 1983;197:276–283.
  • Msuya CA, Hartveit F. Skip lesions in the axilla in breast cancer, and their association with micrometastases. Breast Cancer Res Treat. 1991;19:277–281.
  • Lloyd LR, Waits RK, Jr., Schroder D, Axillary dissection for breast carcinoma: the myth of skip metastasis. Am Surg. 1989;55:381–384.
  • Veronesi U, Rilke F, Luini A, Distribution of axillary node metastases by level of invasion. An analysis of 539 cases. Cancer 1987;59:682–687.
  • Senofsky GM, Moffat FL, Jr., Davis K, Total axillary lymphadenectomy in the management of breast cancer. Arch Surg. 1991;126:1336–1341; discussion 1341–1332.
  • Keskek M, Balas S, Gokoz A, Re-evaluation of axillary skip metastases in the era of sentinel lymph node biopsy in breast cancer. Surg Today 2006;36:1047–1052.
  • Jatoi I. Management of the axilla in primary breast cancer. Surg Clin North Am. 1999;79:1061–1073.
  • Singletary SE, Allred C, Ashley P, Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol. 2002;20:3628–3636.
  • Berg JW. The significance of axillary node levels in the study of breast carcinoma. Cancer 1955;8:776–778.
  • Canavese G, Catturich A, Vecchio C, Prognostic role of lymph-node level involvement in patients undergoing axillary dissection for breast cancer. Eur J Surg Oncol. 1998;24:104–109.
  • Kebudi A, Işgör A, Atay M, The safety and accuracy of sentinel-node biopsy in early-stage invasive breast cancer—Turkish experience. J Invest Surg. 2005;18:129–134.
  • Stewart KC, Lyster DM. Interstitial lymphoscintigraphy for lymphatic mapping in surgical practice and research. J Invest Surg. 1997;10:249–262.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.